Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe +7 more·2015·Nature Communications

DOI 10.1038/ncomms7744

Cited by (1,000)

Items 701–800 of 1,000

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins
Manabu Sasada, Takuya Iyoda, Tatsufumi Asayama, Yusuke Suenaga, Shunsuke Sakai, Naoya Kase, Hiroaki Kodama, Sana Yokoi, Yoichiro Isohama, Fumio Fukai · 2019 · Oncotarget
NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer
Qiuxia Xiong, Songqing Fan, Lincan Duan, Baiyang Liu, Xiulin Jiang, Xiaobo Chen, Chunyan Xiong, Qingyuan Tao, Juan Wang, Hui Zhang et al. · 2020 · Molecular Medicine Reports
Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review
Anup Kasi, Mohammed Al‐Jumayli, Robin Park, Joaquina Celebre Baranda, Weijing Sun · 2020 · Journal of Pancreatic Cancer
High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma
Eric U. Russ, Krithika Bhuvaneshwar, Guisong Wang, Benjamin Jin, Michele Maiko Gage, Subha Madhavan, Yuriy Gusev, Geeta Upadhyay · 2021 · Oncotarget
The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients
Shiwei Guo, Xiaohan Shi, Suizhi Gao, Qunxing Hou, Lisha Jiang, Bo Li, Jing Shen, Huan Wang, Shuo Shen, Guoxiao Zhang et al. · 2021 · Frontiers in Oncology
Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy
Juan Du, Xin Qiu, Changchang Lu, Yahui Zhu, Weiwei Kong, Mian Xu, Xin Zhang, Min Tang, Jun Chen, Qi Li et al. · 2022 · Frontiers in Oncology
Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer
Brittany Rupp, Sarah Owen, Harrison Ball, Kaylee Judith Smith, Valerie Gunchick, Evan T. Keller, Vaibhav Sahai, Sunitha Nagrath · 2022 · International Journal of Molecular Sciences
Animal models of pancreatic cancer and their application in clinical research
Christopher James Scarlett, Judith Weidenhofer, Emily K. Colvin, Danielle R. Bond · 2016 · Gastrointestinal Cancer Targets and Therapy
Molecular Characteristics of Pancreatic Ductal Adenocarcinomas with High-Grade Pancreatic Intraepithelial Neoplasia (PanIN) Are Different from Those without High-Grade PanIN
Tetsuyuki Miyazaki, Yoshihiro Ohishi, Yoshihiro Miyasaka, Yasunori Oda, Shinichi Aishima, Keigo Ozono, Atsushi Abe, Eishi Nagai, Masafumi Nakamura, Yoshinao Oda · 2017 · Pathobiology
A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery
Elizabeth A. McMillan, Gino Kwon, Jean Rene V. Clemenceau, Kurt W. Fisher, Rachel M. Vaden, Anam F. Shaikh, Beth K. Neilsen, David Kelly, Malia B. Potts, Yeo-Jin Sung et al. · 2019 · Cell chemical biology
A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer
Hongcao Lin, Chonghui Hu, Shangyou Zheng, Xiang Zhang, Rufu Chen, Quanbo Zhou · 2021 · Aging
Neoplastic Progression in Macroscopic Precursor Lesions of the Pancreas
Elizabeth D. Thompson · 2024 · Archives of Pathology & Laboratory Medicine
A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibitors
Rong Fu, Chunbin Wang, Tongjin Yin, Xuyao Zhang, Ying Xu, Yue Shi, Jing Xu, Wei Zhang, Zhe Ding · 2025 · International Journal of Molecular Medicine
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database
Abrahm Levi, Edik Matthew Blais, John Davelaar, Matthew Ebia, Angela Minasyan, Nima Nikravesh, Gillian K. Gresham, Lei Zheng, Jennifer W. Chuy, Rachna T. Shroff et al. · 2025 · The Oncologist
The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulation
Daisuke Kyuno, Hinae Asano, Reona Okumura, Kumi Takasawa, Akira Takasawa, Takumi Konno, Yuna Nakamori, Kazufumi Magara, Yusuke Ono, Masafumi Imamura et al. · 2025 · Cancers
Endoscopic Ultrasound-Guided Pancreatic Cystic Fluid Biochemical and Genetic Analysis for the Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions
Angelo Bruni, Luigi Tuccillo, Giuseppe Dell’Anna, Francesco Vito Mandarino, Andrea Lisotti, Marcello Fabio Maida, Claudio Ricci, Lorenzo Fuccio, Leonardo Henry Eusebi, Giovanni Marasco et al. · 2025 · Journal of Clinical Medicine
Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
Alejandro Jiménez-Sánchez, Sitara Persad, Akimasa Hayashi, Shigeaki Umeda, Roshan Sharma, Yubin Xie, Arnav Mehta, Wungki Park, Ignas Masilionis, Tinyi Chu et al. · 2025 · Cancer Research
KRAS Inhibition in Pancreatic Ductal Adenocarcinoma
Roshini Pradeep, Nooredeen Jamal Isbeih, Freya F. Abraham, Ehsan Noori, Zachary Phillip Yeung, Madappa N. Kundranda · 2026 · Journal of Clinical Medicine
Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas
Taisuke Imamura, Ryo Ashida, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Sumiko Ohnami, Takeshi Nagashima, Ken Yamaguchi · 2022 · Annals of Gastroenterological Surgery
Identification of a novel mitochondria-localized LKB1 variant required for the regulation of the oxidative stress response
Ivan Tan, Shengli Xu, Jianxin Huo, Yuhan Huang, Hong Hwa Lim, Kong‐Peng Lam · 2023 · Journal of Biological Chemistry
Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging
Yoghalakshmi Nagarajan, Natarajan Chandrasekaran, Venkatachalam Deepa Parvathi · 2024 · ChemistryOpen
The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
Ashleigh Parkin, Jennifer Man, Angela S. Y. Chou, Adnan M. Nagrial, Jaswinder Singh Samra, Anthony James Gill, Paul Timpson, Marina Pajic · 2018 · Diseases
Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis
Wei-Chia Hung, Der‐Yen Lee, En‐Pei Isabel Chiang, Jia‐Ning Syu, Che‐Yi Chao, Mei‐Due Yang, Shu-Yao Tsai, Feng‐Yao Tang · 2020 · PLoS ONE
Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle Biopsy
Joo Kyung Park, Hye Min Kim, Dae‐Soon Son, Nayoung K. D. Kim, Young Kyung Sung, Minseob Cho, Chung Lee, Dong Hyo Noh, Se‐Hoon Lee, Kyu Taek Lee et al. · 2021 · Cancers
Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma
Yinlei Dong, Junjie Tian, Bingqian Yan, Kun Lv, Ji Li, Deliang Fu · 2021 · Pathology & Oncology Research
EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy
Joanne Lundy, Marion Harris, John Raymond Zalcberg, Allan Solomon Zimet, David Goldstein, Val Gebski, Adina Borsaru, Christopher Desmond, Michael P. Swan, Brendan John Jenkins et al. · 2021 · Frontiers in Oncology
Discoveries in Pancreatic Physiology and Disease Biology Using Single-Cell RNA Sequencing
Haotian Fu, Hongwei Sun, Hongru Kong, Bin Lou, Hao Chen, Yilin Zhou, Chaohao Huang, Lei Qin, Yunfeng Shan, Shengjie Dai · 2022 · Frontiers in Cell and Developmental Biology
A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer
Sara Mainardi, René Bernards · 2022 · Cell Genomics
Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
Kjersti Tjensvoll, Morten Lapin, Bjørnar Gilje, H. Garresori, Satu Oltedal, R. Forthun, A. Molven, Y. Rozenholc, O. Nordgård · 2022 · Scientific Reports
An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer
Iris J. M. Levink, Malgorzata Ilona Srebniak, Walter G. de Valk, Monique M. van Veghel–Plandsoen, Anja Wagner, Djuna L. Cahen, Gwenny Manel Fuhler, Marco J. Bruno · 2023 · International Journal of Molecular Sciences
Detection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens
Eleni G. Christodoulou, Hai Yang, Franziska Lademann, Christian P. Pilarsky, Andreas Beyer, Michael Schroeder · 2017 · Oncotarget
Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies
Waïsse Waïssi, A. Paix, Anaïs Nicol, Georges Noël, Hélène Burckel · 2020 · Critical Reviews in Oncology/Hematology
Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
Ryan R. Kawalerski, Steven D. Leach, Luisa F. Escobar‐Hoyos · 2021 · Oncotarget
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
Elisabetta Pietri, Rita Balsano, Matilde Corianò, Fabio Gelsomino, Francesco Leonardi, Simona Bui, Letizia Gnetti, Raffaele Dalla Valle, Ingrid Garajová · 2021 · Cancer Drug Resistance
Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care
Andrew J. Aguirre · 2018 · Gastroenterology
Heavy mutagenesis by tobacco leads to lung adenocarcinoma tumors with KRAS G12 mutations other than G12D, leading KRAS G12D tumors—on average—to exhibit a lower mutation burden
Chichun Tan, Jeffrey D. Mandell, Krishna Dasari, Vincent L. Cannataro, Jorge A. Alfaro-Murillo, Jeffrey P. Townsend · 2021 · Lung Cancer
RETRACTED: SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells
Yonghe Li, Patsy G. Oliver, Wenyan Lü, Vibha Pathak, Sivaram Sridharan, Corinne E. Augelli‐Szafran, Donald J. Buchsbaum, Mark J. Suto · 2016 · Cancer Letters · Retracted
Multidimensional analyses identify genes of high priority for pancreatic cancer research
Zeribe C. Nwosu, Heather M. Giza, Maya Nassif, Verodia Charlestin, Rosa Elena Menjivar, Dae-Ho Kim, Samantha B. Kemp, Peter Sajjakulnukit, Anthony C. Andren, Li Zhang et al. · 2025 · JCI Insight
Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities
Zhe Jiang, Michelle S. Allkanjari, Philip E.D. Chung, Hanna Tran, Ronak Ghanbari-Azarnier, Dong‐Yu Wang, Dan C.C. Lin, Jung Yeon Min, Yaacov Ben‐David, Eldad Zacksenhaus · 2025 · Cancers
Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies
Dharini Srinivasan, Johann Gout, Alexander Kleger, Élodie Roger · 2025 · Advanced Drug Delivery Reviews
Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis
Mette M. Steiniche, Louise Bach Callesen, Elizabeth H. Vlk, Lise Ventzel, Signe Timm, Rikke Fredslund Andersen, Sidsel C. Lindgaard, Torben F. Hansen, Morten Bækbo Ladekarl, Karen‐Lise Garm Spindler · 2025 · The Journal of Liquid Biopsy
Analysis of KRAS Mutations in Gastrointestinal Tract Adenocarcinomas Reveals Site-Specific Mutational Signatures
Linyuan Wang, Bejan Jon Saeedi, Zaid K Mahdi, Alyssa M. Krasinskas, Brian Scott Robinson · 2023 · Modern Pathology
Cheminformatics and Bioinformatics at the Interface with Systems Biology
Aman Chandra Kaushik, Aamir Mehmood, Dong‐Qing Wei, Sadia Nawab, Shakti Sahi, Ajay Kumar · 2023 · Royal Society of Chemistry eBooks
Long-term survival after resection of invasive pancreatic intraductal papillary mucinous neoplasm
Pietro Addeo, Giulia Canali, Chloé Paul, Pierre de Mathelin, Gerlinde Avérous, Philippe Bachellier · 2024 · Langenbeck s Archives of Surgery
Targeting KRAS and the vitamin D receptor via microtubules
Agnès Basseville, Susan Elaine Bates, Tito Fojo · 2015 · Nature Reviews Clinical Oncology
Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel
Daniela Bianconi, Gerwin Heller, Daniel Spies, Merima Herac, Andreas Gleiß, Sandra Liebmann‐Reindl, Matthias Unseld, Markus Kieler, Werner Scheithauer, Berthold Streubel et al. · 2017 · Scientific Reports
PMTDS: a computational method based on genetic interaction networks for Precision Medicine Target‐Drug Selection in cancer
Varshini Vasudevaraja, Jamie L. Renbarger, Ridhhi Girish Shah, Garrett H. Kinnebrew, Murray Korc, Limei Wang, Yang Huo, Enze Liu, Lang Li, Lijun Cheng · 2017 · Quantitative Biology
Biomarkers to diagnose metastatic breast carcinoma to the pancreas: A case report and update
Kevin Shee, Alexander M. Strait, Xiaoying Liu · 2019 · Diagnostic Cytopathology
Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer
Sushmitha Sankarasubramanian, Ulrike Pfohl, Christian R. A. Regenbrecht, Christoph Reinhard, Lena Wedeken · 2021 · Frontiers in Cell and Developmental Biology
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
Maroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, Youssef Bouferraa, Morgan Bou Zerdan, Sabine Allam, Merima Ramovic-Zobic, Stephen L. Graziano · 2022 · Cancers
Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the “precision medicine” of pancreatic cancer
Naohiko Yoshizawa, Reiko Yamada, Takashi Sakuno, Hiroyuki Inoue, Hiroshi Miura, Toshifumi Takeuchi, Misaki Nakamura, Yasuhiko Hamada, Masaki Katsurahara, Kyosuke Tanaka et al. · 2018 · Medicine
Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis
Congya Zhou, Liuyun Gong, Rong Liao, Ningna Weng, Yao‐Yue Feng, Yiping Dong, Hong Zhu, Yaqin Zhao, Yuanyuan Zhang, Qing Zhu et al. · 2019 · Oncology Letters
Biology, pathophysiology, and epidemiology of pancreatic cancer
Begum Dariya, Afroz Alam, Ganji Purnachandra Nagaraju · 2019 · Elsevier eBooks
Integrated analysis of gene expression, alteration and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer
Chun‐Yue Weng, Xinyi Hu, Yajun Wang · 2020 · 3 Biotech
The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial
Daniel Gerald Croagh, Samar Masoumi-Moghaddam, Joanne Lundy, Hugh Gao, Vivek Rathi, Michael P. Swan, Christopher Desmond, ManoopS Bhutani, MelissaC Southey, Rhys Vaughan et al. · 2021 · Endoscopic Ultrasound
Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients
Shannon R. Nelson, Naomi Walsh · 2020 · Cancers
An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course
Zachary A. Kohutek, Lauren M. Rosati, Junguei Hong, Justin Poling, Marc A. Attiyeh, Alvin P. Makohon-Moore, Joseph M. Herman, Christine A. Iacobuzio–Donahue · 2017 · Molecular Case Studies
Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex
Marzieh Jamali, Erfaneh Barar, Jiaqi Shi · 2024 · International Journal of Molecular Sciences
Preoperative Prognostic Factors in Resectable Pancreatic Cancer: State of the Art and Prospects
Mehdi Boubaddi, Julia Rossi, Arthur Marichez, Marion Marty, Samuel Amintas, Christophe Laurent, Sandrine Dabernat · 2025 · Annals of Surgical Oncology
Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
Sara Barrambana, Elena Zamorano-Domínguez, Vasiliki Liaki, Carmen E. Guerra · 2025 · Advanced Drug Delivery Reviews
Strategies for the drug development of cancer therapeutics
Hongyan Liu, Yanpin Ma, Wenjuan Chen, Xinyu Gu, Jiachun Sun, Penghui Li · 2025 · Frontiers in Pharmacology
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1
Jean–Luc Van Laethem, Karen Paula Geboes, Ivan Borbath, Teresa Mercade Macarulla, Aurélien Lambert, Philippe Alexandre Cassier, Hans Prenen, Emmanuel Mitry, Jean‐Frédéric Blanc, Lorenzo Pilla et al. · 2025 · Cell Reports Medicine
The hallmarks of pancreatic cancer
Laura E. Kane, David Hackett, Rebecca G. Lyons, Barbara Mary Ryan, Stephen G. Maher · 2026 · Cancer Letters
High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma
Sönke Detlefsen, Henning B. Boldt, Mark Burton, Mikkel Marschall Thomsen, Lukas Gammelgaard Rasmussen, Siri Vreim Ørbeck, Per Pfeiffer, Michael Bau Mortensen, Karin de Stricker · 2023 · Human Pathology
Codon-specific KRAS mutations predict survival in advanced pancreatic cancer
Alice Boilève, Adrien Rousseau, Marc Hilmi, Anthony Tarabay, Jacques R.R. Mathieu, Jérôme Cartry, Sabrina Bedja, N. Goudarzi, Claudio Nicotra, Maud Ngo‐Camus et al. · 2024 · ESMO Gastrointestinal Oncology
Analysis of mutations of PARP1, RNF213, PAX8, KMT2C, MTRR in malignant mesothelioma of testicular tunica vaginalis testis
Artur Kowalik, Andrzej Wincewicz, Sebastian Zięba, Wojciech Baran, Janusz Kopczyński, Mariusz Koda, Stanislaw Sulkowski, Stanisław S. Góźdź · 2020 · Polish Journal of Pathology
Clinical implications of the molecular characterization of intraductal papillary mucinous neoplasms of the pancreas
Nicholas V. Peters, John W. Kunstman · 2021 · Journal of Cancer Metastasis and Treatment
KRAS mutation allele frequency threshold alters prognosis in right‐sided resected pancreatic cancer
David O. Nauheim, David Moskal, Bryan Renslo, Matthew Chadwick, Wei Jiang, Charles J. Yeo, Avinoam Nevler, Wilbur Bo Bowne, Harish Lavu · 2022 · Journal of Surgical Oncology
Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma
Bixi Zhang, Qing Hu, Yanchun Li, Canxia Xu, Xiaoran Xie, Peng Liu, Meihua Xu, Siming Gong, Hao Wu · 2022 · Frontiers in Molecular Biosciences
High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in PDAC
Takahiro Kasai, Shoma Tamori, Y Takasaki, Izumi Matsuoka, Ayaka Ozaki, Chika Matsuda, Yohsuke Harada, Kazunori Sasaki, Shigeo Ohno, Kazunori Akimoto · 2023 · Biochemical and Biophysical Research Communications
Synthesis of DNA‐Boron Cluster Composites and Assembly into Functional Nanoparticles with Dual, Anti‐EGFR, and Anti‐c‐MYC Oncogene Silencing Activity
Katarzyna Bednarska, Katarzyna Ebenryter‐Olbińska, Gabriela Gajek, Krzysztof Śmiałkowski, Justyna Suwara, Lidia Fiedorowicz, Zbigniew Jan Lesnikowski · 2024 · Chemistry - A European Journal
Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer
Soon‐Chan Kim, Ha‐Young Seo, Ja-Oh Lee, Ju Eun Maeng, Young‐Kyoung Shin, Sang Hyub Lee, Jin‐Young Jang, Ja‐Lok Ku · 2024 · Cellular Oncology
A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing
Ki Hwan Hong, Soyoung Song, Wonseok Shin, Keunsoo Kang, Chun-Sung Cho, Yong Tae Hong, Kyudong Han, Jeong Hwan Moon · 2018 · Genes & Genomics
Sensitive and specific post-call filtering of genetic variants in xenograft and primary tumors
Brian K. Mannakee, Uthra Balaji, Agnieszka Katarzyna Witkiewicz, Ryan N. Gutenkunst, Erik S. Knudsen · 2018 · Bioinformatics
Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern
Paulina Sánchez, Magali Espinosa, Vilma Maldonado, Rodrigo Barquera, Nayeli Belem Gabiño‐López, Javier Torres, Adrián Cravioto-Villanueva, Jorge Meléndez-Zajgla · 2020 · Molecular Biology Reports
Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
Yoelsis Garcia‐Mayea, Lisandra Benítez-Álvarez, Almudena Sánchez-García, Marina Bataller, Osmel Companioni, Cristina Mir, Sergi Benavente, Juan Lorente, Núria Canela-Canela, Ceres Fernández–Rozadilla et al. · 2022 · Cancers
Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights
Andre Ene, Jing Di, Janna H. Neltner, Thomas A. Pittman, Susanne M. Arnold, Jill Kolesar, John Lee Villano, Sara Emily Bachert, Derek B. Allison · 2023 · Frontiers in Oncology
On the behaviour of permutation‐based variable importance measures in random forest clustering
Stefano Nembrini, Tiziano Frigoli · 2019 · Journal of Chemometrics
Vertical nanopillar induces deformation of cancer cell and alteration of ATF3 expression
Jing Dai, Yi Lü, Xue‐Yan He, Chao Zhong, Bo‐Lin Lin, Shengjie Ling, Jinkang Gong, Yuan Yao · 2020 · Applied Materials Today
Impact of Ethnicity on Somatic Mutation Rates of Pancreatic Adenocarcinoma
Nayra Soares do Amaral, Vívian Resende, José Sebastião dos Santos, Luiz Felipe Lima, Débora Chaves Moraes, Eitan Friedman, Luiz Armando De Marco, Luciana Bastos‐Rodrigues · 2018 · In Vivo
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?
Dimitra Grapsa, M. W. Saif, Konstantinos Syrigos · 2015 · World Journal of Gastrointestinal Oncology
Should We Lower Our Threshold for Germline Genetic Assessment in Pancreatic Adenocarcinoma?
Alicia J. Latham, Zsofia Kinga Stadler · 2018 · JCO Precision Oncology
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma
Jun Zhong, Aidan O’Brien, Minal B. Patel, Daina Eiser, Michael Mobaraki, Irene J. Collins, Li Wang, Konnie Guo, ThucNhi TruongVo, Ashley A. Jermusyk et al. · 2025 · Gut
Immunomodulation of Pancreatic Cancer via Inhibition of SUMOylation and the CD155/TIGIT Pathway
Jorge De la Torre, Utsav Joshi, Himangshu Sonowal, Yixuan Kuang, Tianchen Ren, Dai-Hua Chen, M.D. Neranjan Tharuka, Kim Nguyen-Ta, Helene L. Gros, Zbigniew Mikulski et al. · 2025 · Molecular Cancer Therapeutics
Pancreatic Cancer Organoids Recapitulate Chemotherapy Response and Identify a Potent Cytotoxic T-Cell Population
Renee R. Anderko, Alexandra E Bowman, Praneel Murthy, Pranav Murthy, Asmita Chopra, Nikhil V. Tirukkovalur, Sebastiaan Ceuppens, Alessandro Paniccia, Kenneth K.W. Lee, Robbie B. Mailliard et al. · 2025 · Clinical Cancer Research
NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress
Yi Xu, Michael H Nipper, Angel A. Dominguez, Chenhui He, Francis E. Sharkey, Sajid Khan, Han Xu, Daohong Zhou, Lei Zheng, Yu Luan et al. · 2026 · Journal of Clinical Investigation
Targeting the alterations of ARID1A in pancreatic cancer: tumorigenesis, prediction of treatment, and prognostic value.
Ruichao Li, Guangbing Xiong, Jun Zhao, Lin Yang · 2022 · PubMed Central
Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling
Dandan Li, Anne M. Miermont, Rushikesh V. Sable, Humair S. Quadri, Lesley A. Mathews Griner, Scott E. Martin, Taivan Odzorig, Soumita De, Marc Ferrer, Astin S. Powers et al. · 2023 · Molecular Cancer Research
Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy
Barbara Geerinckx, Laure-Anne Marie Nicole Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Jay Price · 2023 · Expert Review of Anticancer Therapy
Focus on RAS Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis
Francesco Schietroma, Annunziato Anghelone, Giustina Valente, Viria Beccia, Giulia Caira, Alexia Spring, Giovanni Trovato, Armando Di Bello, Anna Ceccarelli, Laura Chiofalo et al. · 2024 · Cancers
Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy
Julie Buchberg, Karin de Stricker, Per Pfeiffer, Michael Bau Mortensen, Sönke Detlefsen · 2024 · Endoscopic Ultrasound
Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine
Joseph W. George, Mika Bessho, Tadayoshi Bessho · 2019 · Journal of Nucleic Acids
Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen
Trine Aaquist, Maja Dembić, Mads Thomassen, Karin de Stricker, Mette Bertelsen, Lene Gaarsmand Christensen, Michael Bau Mortensen, Sönke Detlefsen · 2021 · Pathology - Research and Practice
On the behaviour of permutation‐based variable importance measures in random forest clustering
Stefano Nembrini · 2019 · Journal of Chemometrics
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
Renato B. Baleeiro, Louisa S. Chard, Peng Liu, Shuangshuang Lu, Yu Chun Lone, Nicholas Robert Lemoine, Yaohe Wang · 2022 · Frontiers in Immunology
Gene Coexpression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target
Chengsi Wu, Yizhen Liu, Dianhui Wei, Liyuan Tao, Lili Yuan, Tiantian Jing, Boshi Wang · 2022 · Frontiers in Oncology
Pancreatic Adenocarcinoma with Co-Occurrence of KRAS and EGFR Mutations: Case Report and Literature Review
Juhi Mody, Mandana Kamgar · 2024 · Case Reports in Oncology
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients
Xiaoyi Yin, Hui Shen, Huan Wang, Qingchen Wang, Shan Zhang, Chunming Zhang, Qi Jia, Shiwei Guo, Xiongfei Xu, Wenhui Zhang et al. · 2025 · Nature Communications
The Relationship Between DOT1L, Histone H3 Methylation, and Genome Stability in Cancer
Brent J. Guppy, Lucile M. Jeusset, Kirk James McManus · 2017 · Current Molecular Biology Reports
Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer
Yanan Pang, Zhiyong Liu, Shanrong Liu · 2018 · Pathology & Oncology Research